(2)
EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida.
CRYO will optimize cell recovery from the umbilical cord to supply umbilical cord cells under its previously announced CRADA agreement with the Biomedical Research Laboratory in Bethesda, Maryland, and for future IND application(s). The Agreement includes BTL marketing CRYO s products and services, and collaborative R&D efforts related to developing and improving protocols utilizing both CRYO s ATCell
American CryoStem and BioTherapeutic Labs Corp Enter into R&D, Collaboration and Marketing Agreement
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
American CryoStem and BioTherapeutic Labs Corp Enter into R&D, Collaboration and Marketing Agreement
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
(1)
EATONTOWN, NJ / ACCESSWIRE / January 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology Company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) authorized by published code 15 U.S.C. 3710a of US Title 15 Commerce and Trade. (https://www.disa.mil/about/cto/crada-process-overview
) The Collaborative work will be conducted at the Biomedical Research Laboratory in Bethesda, Maryland.
The non-human research Collaboration entitled Stem Cells for Regeneration and Medical Innovation is a multi-faceted and multi-staged project centered on creating in vitro (test tube) assays to standardize and commercialize new treatment protocols; optimize quality control measures; and develop standardized protocol potency assays for precise therapy dosing. The Collaborative team plans to (a) validate and standardize baseline and assay
American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.